- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
EXHIBIT 15.1
Letter Re Unaudited Interim Financial Information
August 14, 2006
Cytori Therapeutics, Inc.
3020 Callan Rd
San Diego, CA 92121
Re: Registration Statement Nos. 333-82074, 333-122691, and 333-134129
With respect to the subject registration statements, we acknowledge our awareness of the use therein of our report dated August 14, 2006 related to our review of interim financial information.
Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.
/s/ KPMG LLP |
|
|
|
|
|
|
|
|
San Diego, California |
|